Study provides new look at why rare cancer often evades treatments
Por um escritor misterioso
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
How a clinical trial cured cancer — in some cases — WHYY
Scientists reveal how proteins drive growth of multiple cancer types – Washington University School of Medicine in St. Louis
Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights
What is tumor-infiltrating lymphocyte (TIL) therapy?
Recent Advances in Nanoparticle-Based Cancer Treatment: A Review
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
Scientists Diagnose Dinosaur With Malignant Bone Cancer - Cancer Health
Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy
CRISPR in Cancer Therapeutics: CAR T, NK, TCR and Beyond
Squamous Cell Carcinoma (SCC) Symptoms, Stages, Risk Factors and Treatment
The future of early cancer detection
de
por adulto (o preço varia de acordo com o tamanho do grupo)